keyword
https://read.qxmd.com/read/37239261/il-10-%C3%AE-endorphin-mediated-neuroimmune-modulation-on-microglia-during-antinociception
#1
REVIEW
Thiago Caetano Andrade Belo, Gabriela Xavier Santos, Bruno Eduardo Gabriel da Silva, Bruno Lopes Gonçalves Rocha, Dennis William Abdala, Larissa Alves Moreira Freire, Fernanda Santos Rocha, Giovane Galdino
Microglia are glial cells centrally related to pathophysiology and neuroimmunological regulation of pain through microglia-neuron crosstalk mechanisms. In contrast, anti-inflammatory mechanisms guided by immunological effectors such as IL-10 trigger the secretion of analgesic substances, culminating in the differential expression of genes encoding endogenous opioid peptides, especially β-endorphin. Thus, when β-endorphin binds to the µ-opioid receptor, it generates neuronal hyperpolarization, inhibiting nociceptive stimuli...
May 12, 2023: Brain Sciences
https://read.qxmd.com/read/36538623/palmitic-acid-methyl-ester-induces-cardiac-hypertrophy-through-activating-the-gpr-receptor-mediated-changes-of-intracellular-calcium-concentrations-and-mitochondrial-functions
#2
JOURNAL ARTICLE
Chih-Feng Lien, Hung-Wen Chiu, Wen-Sen Lee, Jian-Hong Lin, Yi-Shun Wang, Pei-Ching Ting, Yu-Po Luo, Jui-Chih Chang, Kun-Ta Yang
Myocardial hypertrophy is associated with a significant increase in intracellular Ca2+ , which can be induced by long-chain fatty acid. Palmitic acid methyl ester (PAME), a fatty acid ester released from adipose tissue, superior cervical ganglion, and retina, has been found to have anti-inflammation, antifibrosis, and peripheral vasodilation effects. However, the effects of PAME on cardiomyocytes are still unclear. The aim of this study was to determine whether PAME could disrupt the intracellular Ca2+ balance, leading to cardiomyocyte hypertrophy...
December 20, 2022: Journal of Cellular Physiology
https://read.qxmd.com/read/33100202/recent-updates-on-free-fatty-acid-receptor-1-gpr-40-agonists-for-the-treatment-of-type-2-diabetes-mellitus
#3
JOURNAL ARTICLE
Lata Rani, Ajmer Singh Grewal, Neelam Sharma, Sukhbir Singh
BACKGROUND: The disturbing incidence of type 2 diabetes mellitus (T2DM) enthused the development of newer antidiabetic targets with low toxicity and longer stability. In this respect, free fatty acid receptor 1 (FFAR1), also recognized as G protein-coupled receptor 40 (GPR40) is novel target for the treatment of T2DM. FFAR1/GPR40 have high level of expression in β-cells of pancreas and requirement of glucose for stimulating insulin release results in immense stimulation to utilise these targets in the medication of T2DM...
October 23, 2020: Mini Reviews in Medicinal Chemistry
https://read.qxmd.com/read/26116229/rosiglitazone-inhibition-of-calvaria-derived-osteoblast-differentiation-is-through-both-of-ppar%C3%AE-and-gpr40-and-gsk3%C3%AE-dependent-pathway
#4
JOURNAL ARTICLE
Xiao-Lu Tang, Chang-Nan Wang, Xiao-Yan Zhu, Xin Ni
Rosiglitazone (RSG) can cause bone loss, however the mechanisms remain largely unknown. This study aims to investigate the effects of RSG on differentiation and mineralization of osteoblasts using primary cultured mouse fetal calvaria-derived osteoblasts as a model, and elucidate the receptor and signaling pathways responsible for these effects. We found that RSG suppressed the differentiation and mineralization of calvaria-derived osteoblasts. Peroxisome proliferators-activated receptor γ (PPARγ) siRNA significantly reversed the inhibitory effect of RSG on osteogenic differentiation...
September 15, 2015: Molecular and Cellular Endocrinology
https://read.qxmd.com/read/23335512/the-free-fatty-acid-receptor-g-protein-coupled-receptor-40-gpr40-protects-from-bone-loss-through-inhibition-of-osteoclast-differentiation
#5
JOURNAL ARTICLE
Fabien Wauquier, Claire Philippe, Laurent Léotoing, Sylvie Mercier, Marie-Jeanne Davicco, Patrice Lebecque, Jérôme Guicheux, Paul Pilet, Elisabeth Miot-Noirault, Vincent Poitout, Thierry Alquier, Véronique Coxam, Yohann Wittrant
The mechanisms linking fat intake to bone loss remain unclear. By demonstrating the expression of the free fatty acid receptor G-coupled protein receptor 40 (GPR40) in bone cells, we hypothesized that this receptor may play a role in mediating the effects of fatty acids on bone remodeling. Using micro-CT analysis, we showed that GPR40(-/-) mice exhibit osteoporotic features suggesting a positive role of GPR40 on bone density. In primary cultures of bone marrow, we showed that GW9508, a GRP40 agonist, abolished bone-resorbing cell differentiation...
March 1, 2013: Journal of Biological Chemistry
https://read.qxmd.com/read/22275065/inhibition-of-gpr40-protects-min6-%C3%AE-cells-from-palmitate-induced-er-stress-and-apoptosis
#6
JOURNAL ARTICLE
Jinwei Wu, Peng Sun, Xiaodong Zhang, Hong Liu, Hualiang Jiang, Weiliang Zhu, Heyao Wang
Chronic exposure to elevated concentration of free fatty acids (FFA) has been verified to induce endoplasmic reticulum (ER) stress, which leads to pancreatic β-cell apoptosis. As one of the medium and long chain FFA receptors, GPR40 is highly expressed in pancreatic β cells, mediates both acute and chronic effects of FFA on β-cell function, but the role of GPR40 in FFA-induced β-cell apoptosis remains unclear. In this study, we investigated the possible effects of GPR40 in palmitate-induced MIN6 β-cell apoptosis, and found that DC260126, a novel small molecular antagonist of GPR40, could protect MIN6 β cells from palmitate-induced ER stress and apoptosis...
April 2012: Journal of Cellular Biochemistry
https://read.qxmd.com/read/17583366/expression-of-free-fatty-acid-receptor-gpr40-in-the-central-nervous-system-of-adult-monkeys
#7
JOURNAL ARTICLE
Dexuan Ma, Bangbao Tao, Shogo Warashina, Susumu Kotani, Li Lu, Desislav B Kaplamadzhiev, Yoshimi Mori, Anton B Tonchev, Tetsumori Yamashima
The G-protein coupled receptor 40 (GRP40) is a transmembrane receptor for free fatty acids, and is known for its relation to insulin secretion in the pancreas. Recent studies demonstrated that spatial memory and hippocampal long-term potentiation of rodents and cognitive function of humans are improved by a dietary supplementation with arachidonic and/or docosahexaenoic acids, which are possible ligands for GPR40. While free fatty acid effects on the brain might be related to GPR40 activation, the role of GPR40 in the central nervous system (CNS) is at present not known...
August 2007: Neuroscience Research
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.